Clinical trial

Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer

NCT05973149

Study summary

ClinicalTrials.gov

Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention QLH12016 Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-08-31

PhasePHASE1

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

QLH12016DRUG

Sponsors & collaborators

Qilu Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05973149 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.